11 – 20 of 141
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
CITED1 as a marker of favourable outcome in anti-endocrine treated, estrogen-receptor positive, lymph-node negative breast cancer.
(
- Contribution to journal › Article
-
Mark
Sex and gender differences in treatment intention, quality of life and performance status in the first 100 patients with periampullary cancer enrolled in the CHAMP study
(
- Contribution to journal › Article
-
Mark
Imaging ovarian cancer - from baseline characteristics to high-risk image factors
(
- Contribution to journal › Article
-
Mark
Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Impact of Laparoscopic Gastrectomy on the Completion Rate of the Perioperative Chemotherapy Regimen in Gastric Cancer : A Swedish Nationwide Study
(
- Contribution to journal › Article
-
Mark
Trajectories of immune-related serum proteins and quality of life in patients with pancreatic and other periampullary cancer : the CHAMP study
(
- Contribution to journal › Article
-
Mark
Nordic anal cancer (NOAC) group consensus guidelines for risk-adapted delineation of the elective clinical target volume in anal cancer
(
- Contribution to journal › Article
-
Mark
Surgical decision-making following neoadjuvant immunotherapy for dMMR rectal cancer; case reports and review of the literature
(
- Contribution to journal › Article
-
Mark
ASO Author Reflections : The Impact of Minimally Invasive Surgery on the Completion Rate of the Perioperative Chemotherapy Protocol in Gastric Cancer
(
- Contribution to journal › Debate/Note/Editorial
- 2022
-
Mark
A Prospective Diet-Wide Association Study for Risk of Colorectal Cancer in EPIC
(
- Contribution to journal › Article